Next Article in Journal
Rational and Irrational Issues in Breast Cancer Screening
Previous Article in Journal
Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation
Article Menu

Export Article

Open AccessReview
Cancers 2011, 3(1), 241-251;

Targeting Apoptosis Signaling in Pancreatic Cancer

Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528 Frankfurt, Germany
Received: 24 November 2010 / Revised: 5 January 2011 / Accepted: 6 January 2011 / Published: 11 January 2011
Full-Text   |   PDF [218 KB, uploaded 11 January 2011]


The ability to escape apoptosis or programmed cell death is a hallmark of human cancers, for example pancreatic cancer. This can promote tumorigenesis, since too little cell death by apoptosis disturbs tissue homeostasis. Additionally, defective apoptosis signaling is the underlying cause of failure to respond to current treatment approaches, since therapy-mediated antitumor activity requires the intactness of apoptosis signaling pathways in cancer cells. Thus, the elucidation of defects in the regulation of apoptosis in pancreatic carcinoma can result in the identification of novel targets for therapeutic interference and for exploitation for cancer drug discovery. View Full-Text
Keywords: apoptosis; pancreatic cancer; TRAIL; IAPs; mitochondria apoptosis; pancreatic cancer; TRAIL; IAPs; mitochondria
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Fulda, S. Targeting Apoptosis Signaling in Pancreatic Cancer. Cancers 2011, 3, 241-251.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top